OA12505A - Method of inhibiting adhesion formation. - Google Patents
Method of inhibiting adhesion formation. Download PDFInfo
- Publication number
- OA12505A OA12505A OA1200300271A OA1200300271A OA12505A OA 12505 A OA12505 A OA 12505A OA 1200300271 A OA1200300271 A OA 1200300271A OA 1200300271 A OA1200300271 A OA 1200300271A OA 12505 A OA12505 A OA 12505A
- Authority
- OA
- OAPI
- Prior art keywords
- het
- 6alkyl
- galkyl
- alkyl
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28269301P | 2001-04-10 | 2001-04-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA12505A true OA12505A (en) | 2006-05-29 |
Family
ID=23082703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200300271A OA12505A (en) | 2001-04-10 | 2002-04-10 | Method of inhibiting adhesion formation. |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1385504B1 (hu) |
| JP (1) | JP4394882B2 (hu) |
| KR (1) | KR20030087069A (hu) |
| CN (1) | CN1248692C (hu) |
| AP (1) | AP2003002894A0 (hu) |
| AT (1) | ATE417612T1 (hu) |
| AU (1) | AU2002305164B2 (hu) |
| BG (1) | BG108217A (hu) |
| BR (1) | BR0208789A (hu) |
| CA (1) | CA2443734A1 (hu) |
| CZ (1) | CZ20032767A3 (hu) |
| DE (1) | DE60230404D1 (hu) |
| EA (1) | EA006202B1 (hu) |
| EC (1) | ECSP034799A (hu) |
| ES (1) | ES2319877T3 (hu) |
| HU (1) | HUP0303725A3 (hu) |
| IL (1) | IL158272A0 (hu) |
| MA (1) | MA26159A1 (hu) |
| MX (1) | MXPA03009344A (hu) |
| NO (1) | NO20034513L (hu) |
| NZ (1) | NZ528577A (hu) |
| OA (1) | OA12505A (hu) |
| PL (1) | PL364526A1 (hu) |
| UA (1) | UA75395C2 (hu) |
| WO (1) | WO2002083125A1 (hu) |
| ZA (1) | ZA200307621B (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008524334A (ja) * | 2004-12-21 | 2008-07-10 | スミスクライン・ビーチャム・コーポレイション | 方法および処方 |
| RU2744540C1 (ru) * | 2020-02-18 | 2021-03-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ профилактики спаечного процесса при операциях на брюшной полости в условиях паренхиматозного кровотечения в эксперименте |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA60311C2 (uk) * | 1996-10-02 | 2003-10-15 | Смітклайн Бічам Корпорейшн | Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція |
-
2002
- 2002-04-10 CA CA002443734A patent/CA2443734A1/en not_active Abandoned
- 2002-04-10 EA EA200301109A patent/EA006202B1/ru not_active IP Right Cessation
- 2002-04-10 WO PCT/US2002/011285 patent/WO2002083125A1/en active IP Right Grant
- 2002-04-10 BR BR0208789-8A patent/BR0208789A/pt not_active IP Right Cessation
- 2002-04-10 HU HU0303725A patent/HUP0303725A3/hu unknown
- 2002-04-10 NZ NZ528577A patent/NZ528577A/en unknown
- 2002-04-10 DE DE60230404T patent/DE60230404D1/de not_active Expired - Lifetime
- 2002-04-10 AU AU2002305164A patent/AU2002305164B2/en not_active Ceased
- 2002-04-10 AP APAP/P/2003/002894A patent/AP2003002894A0/en unknown
- 2002-04-10 PL PL02364526A patent/PL364526A1/xx not_active Application Discontinuation
- 2002-04-10 CZ CZ20032767A patent/CZ20032767A3/cs unknown
- 2002-04-10 KR KR10-2003-7013214A patent/KR20030087069A/ko active IP Right Grant
- 2002-04-10 IL IL15827202A patent/IL158272A0/xx unknown
- 2002-04-10 ES ES02733968T patent/ES2319877T3/es not_active Expired - Lifetime
- 2002-04-10 EP EP02733968A patent/EP1385504B1/en not_active Expired - Lifetime
- 2002-04-10 CN CNB028097874A patent/CN1248692C/zh not_active Expired - Fee Related
- 2002-04-10 AT AT02733968T patent/ATE417612T1/de not_active IP Right Cessation
- 2002-04-10 JP JP2002580929A patent/JP4394882B2/ja not_active Expired - Fee Related
- 2002-04-10 OA OA1200300271A patent/OA12505A/en unknown
- 2002-04-10 MX MXPA03009344A patent/MXPA03009344A/es active IP Right Grant
- 2002-10-04 UA UA2003109182A patent/UA75395C2/uk unknown
-
2003
- 2003-09-30 ZA ZA200307621A patent/ZA200307621B/en unknown
- 2003-10-01 BG BG108217A patent/BG108217A/bg unknown
- 2003-10-06 MA MA27339A patent/MA26159A1/fr unknown
- 2003-10-08 NO NO20034513A patent/NO20034513L/no not_active Application Discontinuation
- 2003-10-09 EC EC2003004799A patent/ECSP034799A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200307621B (en) | 2004-04-21 |
| HUP0303725A2 (hu) | 2004-03-01 |
| EP1385504B1 (en) | 2008-12-17 |
| AP2003002894A0 (en) | 2003-12-31 |
| WO2002083125A1 (en) | 2002-10-24 |
| ATE417612T1 (de) | 2009-01-15 |
| ES2319877T3 (es) | 2009-05-14 |
| JP4394882B2 (ja) | 2010-01-06 |
| NZ528577A (en) | 2005-01-28 |
| JP2004525959A (ja) | 2004-08-26 |
| UA75395C2 (en) | 2006-04-17 |
| ECSP034799A (es) | 2004-01-28 |
| AU2002305164B2 (en) | 2005-07-28 |
| PL364526A1 (en) | 2004-12-13 |
| MA26159A1 (fr) | 2004-07-01 |
| BG108217A (bg) | 2004-12-30 |
| CN1248692C (zh) | 2006-04-05 |
| HUP0303725A3 (en) | 2009-08-28 |
| NO20034513L (no) | 2003-12-04 |
| KR20030087069A (ko) | 2003-11-12 |
| CZ20032767A3 (cs) | 2004-12-15 |
| NO20034513D0 (no) | 2003-10-08 |
| IL158272A0 (en) | 2004-05-12 |
| DE60230404D1 (hu) | 2009-01-29 |
| BR0208789A (pt) | 2004-03-09 |
| CN1509170A (zh) | 2004-06-30 |
| EP1385504A4 (en) | 2007-03-14 |
| EA006202B1 (ru) | 2005-10-27 |
| CA2443734A1 (en) | 2002-10-24 |
| EP1385504A1 (en) | 2004-02-04 |
| MXPA03009344A (es) | 2004-02-12 |
| EA200301109A1 (ru) | 2004-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Crosslinked hyaluronan hydrogels containing mitomycin C reduce postoperative abdominal adhesions | |
| JP2003501151A (ja) | 動脈再狭窄治療用装置および化合物 | |
| PT551182E (pt) | Metodo para tratar a doenca vascular hiperproliferativa | |
| US20050019366A1 (en) | Drug-coated stents and methods of use therefor | |
| JP2000510460A (ja) | スクアラミンを他の抗癌剤と併用する上皮性悪性腫瘍の治療 | |
| EP1447096A1 (en) | Remedies for urinary frequency | |
| PL195136B1 (pl) | Kombinacja zawierająca 5-[4-[2-(N-metylo-N-(2-pirydylo)amino)etoksy]-benzylo] tiazolidyno-2,4-dion i jej zastosowanie | |
| HU212422B (en) | Process for preparing pharmaceutical compositions containing dipyridamole for the treatment of proliferative diseases | |
| PT1365808E (pt) | Composições para tratamento antitumoral contendo ecteinascidina 743 | |
| JP2003519183A (ja) | 心臓および動脈の石灰化を抑制する低用量ビスホスホネートの使用 | |
| SK288707B6 (sk) | Farmaceutické kombinácie obsahujúce antagonistu P2T receptora a ďalšie antitrombotické činidlá, spôsob ich prípravy a ich použitie na liečenie a prevenciu trombózy | |
| BRPI0610498A2 (pt) | uso de roflumilast,composição farmacêutica, produto de combinação e kit para o tratamento de hipertensão pulmonar | |
| OA12505A (en) | Method of inhibiting adhesion formation. | |
| ES2359721T3 (es) | Composición farmacéutica para el tratamiento de fracturas óseas. | |
| JP5244089B2 (ja) | 鎮痛剤およびビタミンを含む医薬組成物 | |
| Cooper et al. | Reduction of post-surgical adhesion formation with tranilast | |
| AU2002305164A1 (en) | Method of inhibiting adhesion formation | |
| KR20050100676A (ko) | 아세틸살리실산 및 안지오텐신 ⅱ 길항제와 배합된디피리다몰의 뇌졸중 예방을 위한 용도 | |
| JP2011148828A (ja) | 非ウィルス性上皮損傷の治療および／または予防 | |
| Rodgers et al. | Reduction of adhesion formation in rabbits by intraperitoneal administration of lazaroid formulations. | |
| US20070149505A1 (en) | Method of Inhibiting Adhesion Formation | |
| US20100305144A1 (en) | Prevention of recurrence of urethral stricture after a conventional treatment | |
| CN108472333A (zh) | 组合 | |
| JPH07196650A (ja) | 平滑筋細胞増殖抑制作用を有するアルガトロバン製剤 | |
| WO2024088712A1 (en) | Mglur5 receptor antagonists for use in prevention and/or treatment of bone marrow lesions (bml) and/or osteoporosis, cartilage loss, osteosclerosis, osteitis in a mammal |